A proposal to use CA-125 to evaluate activity of new antineoplastic agents in ovarian cancer.
Markman
M
M
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D000970:Antineoplastic Agents / Q000592:standards* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood* / Q000188:drug therapy*
D015295:Antigens, Tumor-Associated, Carbohydrate; D000970:Antineoplastic Agents